PWWP2B inhibitors are a class of chemical compounds that target a specific domain within certain proteins, known as the PWWP domain. The PWWP domain, an acronym for Proline-Tryptophan-Tryptophan-Proline, is a protein module found in various chromatin-associated proteins and is characterized by the presence of a conserved proline-tryptophan-tryptophan-proline sequence motif. It typically functions by interpreting the methylation status of histones, which are proteins that help package DNA into structural units called nucleosomes. This domain is involved in the modulation of protein-protein interactions, often influencing the assembly of protein complexes that regulate DNA structure and function. Inhibitors that target the PWWP2B subset of this domain are designed to interfere with these interactions, affecting the ability of the proteins to participate in the regulation of gene expression and the maintenance of genomic integrity.
The design of PWWP2B inhibitors is a complex process that involves understanding the precise structure and function of the PWWP domain. Researchers often utilize crystallography and other structural biology techniques to elucidate the three-dimensional conformation of the domain, which is crucial for the design of molecules that can selectively bind to it. By binding to the PWWP2B domain, these inhibitors can disrupt the normal protein-protein interactions and alter the function of the domain-containing proteins. This action can have downstream effects on the biological pathways in which these proteins are involved. The specificity of PWWP2B inhibitors is a significant focus during the development process, as it is critical to minimize off-target effects that could arise from the inhibition of other PWWP domain-containing proteins. As a result, PWWP2B inhibitors represent a specialized approach in chemical biology, aiming to modulate complex molecular mechanisms at the chromatin level.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Histone deacetylase inhibitor that increases acetylation levels, leading to changes in chromatin structure and transcriptional repression, which can result in decreased expression of PWWP2B due to altered chromatin accessibility. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that leads to hypomethylation of DNA, potentially altering gene expression patterns including downregulation of PWWP2B due to the impact on epigenetic marks. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Another histone deacetylase inhibitor, similar to Trichostatin A, which can lead to transcriptional changes and potentially reduced expression of PWWP2B through altered chromatin dynamics. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
DNA methyltransferase inhibitor that prevents DNA methylation, which might contribute to the downregulation of PWWP2B expression by altering the epigenetic state of its gene. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
A selective histone deacetylase inhibitor affecting gene expression and potentially decreasing PWWP2B levels by modifying chromatin structure and accessibility. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $210.00 $242.00 $1434.00 | 2 | |
Inhibits class I histone deacetylases, leading to chromatin remodeling and potential repression of PWWP2B transcription due to the changes in the epigenetic landscape. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
A hypomethylating agent that can demethylate DNA and potentially suppress PWWP2B expression by altering gene silencing and chromatin structure. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $196.00 | 9 | |
A potent pan-histone deacetylase inhibitor which may cause downregulation of PWWP2B by impacting gene expression profiles through epigenetic modulation. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $214.00 $622.00 | 1 | |
A histone deacetylase inhibitor that alters chromatin structure and can lead to reduced expression of PWWP2B by affecting transcription regulation. | ||||||
Sirtinol | 410536-97-9 | sc-205976 sc-205976A | 1 mg 5 mg | $37.00 $111.00 | 14 | |
An inhibitor of sirtuin histone deacetylases which may impact PWWP2B expression by modifying histone acetylation and thus chromatin accessibility. |